Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECT for schizophrenia.

P Taylor, J J Fleminger

    Lancet (London, England)
    |June 28, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Electroconvulsive therapy (ECT) significantly improved schizophrenia symptoms compared to a sham procedure. While ECT showed early advantages, differences diminished by 16 weeks, suggesting further research is needed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Achalasia of oesophagus, following depressed fracture of base of skull.

    Lancet (London, England)·2010
    Same author

    Setting up a stoma care service.

    Community nurse·1998
    Same author

    Comparison of three monoclonal antibody pools for the detection of respiratory viral antigen in respiratory secretions.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1998
    Same author

    Restrict genetic susceptibility tests.

    Nature·1998
    Same author

    A survey of research in telemedicine. 2: Telemedicine services.

    Journal of telemedicine and telecare·1998
    Same author

    The nurse as patient advocate.

    Nursing·1998
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Neurology

    Background:

    • Schizophrenia treatment remains a challenge.
    • Electroconvulsive therapy (ECT) is a potential therapeutic option.

    Purpose of the Study:

    • To evaluate the efficacy of ECT in treating paranoid schizophrenia.
    • To compare ECT with a sham procedure in a double-blind trial.

    Main Methods:

    • Double-blind, randomized controlled trial with 20 paranoid schizophrenia patients.
    • Comparison between ECT and a sham procedure (no electricity, no induced convulsion).
    • Treatment administered 3 times/week for 8-12 sessions, assessed by Comprehensive Psychiatric Rating Scale.

    Main Results:

    • Both groups showed improvement, but ECT group improvement was significantly greater (p=0.02 after 6 treatments, p=0.004 at end of treatment).

    Related Experiment Videos

  • ECT provided a clear and early clinical advantage over the sham procedure.
  • Differences between groups diminished by 16 weeks post-treatment.

    • Conclusions:

    • ECT demonstrates significant short-term efficacy in improving symptoms of paranoid schizophrenia.
    • The long-term benefits of ECT compared to sham treatment require further investigation.
    • ECT may be a valuable therapeutic option for specific schizophrenia patient populations.